Newly public tech and crypto companies are big beneficiaries of renewed investor interest in the U.S. IPO sector.

Novavax Inc. closed 60.53% below its 52-week high of $17.81, which the company reached on July 26th.

IMAX has strong film pipelines and relationships with studios and directors, reaffirmed by analyst Steve Frankel with a Buy rating and $35 price target.